PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+14.4%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.62B
AUM Growth
+$77.5M
(+5%)
Cap. Flow
-$75.6M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103
Top Buys
| 1 |
NVIDIA
NVDA
|
$4.03M |
| 2 |
Broadcom
AVGO
|
$3.21M |
| 3 |
Tesla
TSLA
|
$2.65M |
| 4 |
Viking Therapeutics
VKTX
|
$1.64M |
| 5 |
Texas Instruments
TXN
|
$1.6M |
Top Sells
| 1 |
AbbVie
ABBV
|
$27.3M |
| 2 |
Danaher
DHR
|
$16.8M |
| 3 |
Amgen
AMGN
|
$12.2M |
| 4 |
Gilead Sciences
GILD
|
$9.54M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$7.75M |
Sector Composition
| 1 | Technology | 33.28% |
| 2 | Healthcare | 16.86% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Communication Services | 8.63% |
| 5 | Energy | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Insmed
INSM
$30.7B
| $1.22M | 0.08% |
+71,395
| New | +$1.22M |
|
252
BHP
BHP
$138B
| $1.22M | 0.08% |
19,188
-2,210
| -10% | -$140K |
|
253
Beam Therapeutics
BEAM
$2.11B
| $1.22M | 0.08% |
39,707
+31,589
| +389% | +$967K |
|
254
Pinterest
PINS
$25.8B
| $1.21M | 0.07% |
44,382
-6,726
| -13% | -$183K |
|
255
Veracyte
VCYT
$2.55B
| $1.21M | 0.07% |
+54,244
| New | +$1.21M |
|
|
JNPR
256
DELISTED
Juniper Networks
JNPR
| $1.2M | 0.07% |
34,816
-4,268
| -11% | -$147K |
|
257
Twist Bioscience
TWST
$1.55B
| $1.2M | 0.07% |
+79,459
| New | +$1.2M |
|
258
PG&E
PCG
$33.2B
| $1.2M | 0.07% |
73,927
-849
| -1% | -$13.7K |
|
259
Blackrock
BLK
$170B
| $1.19M | 0.07% |
1,776
-61
| -3% | -$40.8K |
|
260
Lockheed Martin
LMT
$108B
| $1.19M | 0.07% |
2,507
+165
| +7% | +$78K |
|
261
Gold Fields
GFI
$30.8B
| $1.18M | 0.07% |
88,910
+8,217
| +10% | +$109K |
|
262
Sarepta Therapeutics
SRPT
$1.96B
| $1.18M | 0.07% |
8,592
-1,200
| -12% | -$165K |
|
263
Acadia Pharmaceuticals
ACAD
$4.26B
| $1.18M | 0.07% |
+62,741
| New | +$1.18M |
|
|
MRTX
264
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.17M | 0.07% |
31,527
+25,747
| +445% | +$957K |
|
265
Akero Therapeutics
AKRO
$3.58B
| $1.17M | 0.07% |
+30,578
| New | +$1.17M |
|
266
Cigna
CI
$81.5B
| $1.17M | 0.07% |
4,569
-466
| -9% | -$119K |
|
267
Targa Resources
TRGP
$34.9B
| $1.16M | 0.07% |
15,957
+2,009
| +14% | +$147K |
|
268
Bilibili
BILI
$9.25B
| $1.15M | 0.07% |
48,896
-1,851
| -4% | -$43.5K |
|
269
Kymera Therapeutics
KYMR
$3.11B
| $1.15M | 0.07% |
+38,738
| New | +$1.15M |
|
270
Corteva
CTVA
$49.1B
| $1.15M | 0.07% |
19,011
-1,021
| -5% | -$61.6K |
|
271
Ciena
CIEN
$16.5B
| $1.14M | 0.07% |
21,746
-4,741
| -18% | -$249K |
|
272
Match Group
MTCH
$9.18B
| $1.13M | 0.07% |
29,406
+1,766
| +6% | +$67.8K |
|
273
Monolithic Power Systems
MPWR
$41.5B
| $1.13M | 0.07% |
2,251
+564
| +33% | +$282K |
|
274
Denali Therapeutics
DNLI
$2.26B
| $1.12M | 0.07% |
48,827
+33,960
| +228% | +$782K |
|
275
GE Aerospace
GE
$296B
| $1.11M | 0.07% |
14,579
-4,924
| -25% | -$376K |
|